Glycosylated Hemoglobin in Early Pregnancy as a Marker to Predict Gestational Diabetes Mellitus – A Prospective Cohort Study
DOI:
https://doi.org/10.37506/ijphrd.v11i7.10185Keywords:
Glycosylated hemoglobin, HbA1c, OGTT, GDM predictionAbstract
Objective: To study the usefulness of glycosylated hemoglobin in early pregnancy to predict gestational
diabetes mellitus.
Material and Methods: We conducted this prospective hospital-based observational study over 30 months.
After obtaining university ethics committee clearance, glycosylated hemoglobin (HbA1c) test was performed
during the booking visit in the first trimester amongst 284 antenatal women attending our hospital. This was
followed by the universal screening with 75g OGTT for all antenatal women during 24-28weeks. Gestational
diabetes mellitus (GDM) was diagnosed based on International Association of the Diabetes and Pregnancy
Study Groups (IADPSG) criteria, and treatment started accordingly. Sensitivity and specificity for prediction
of GDM using HbA1c were calculated based on the receiver operating characteristic (ROC) curve.
Results: 70 of the 284 antenatal women were diagnosed with GDM based on IADPSG criteria. The area
under the curve for using HbA1c in early pregnancy to predict GDM was 0.712. A cut-off of 5.55 for HbA1c
gave a sensitivity of 55.7% (95% CI 49.9, 61.4), specificity 83.6% (95% CI 79.3, 87.9), positive predictive
value (PPV) of 41.5% (95% CI 35.8, 47.2) and negative predictive value (NPV) of 83.7% (95% CI 79.4,
88.0).
Conclusion: HbA1c in early pregnancy may be a useful marker in prediction of GDM. A cut-off of >5.55%
may warrant an early OGTT for diagnosis and treatment of early-onset GDM.